Clinical trials

  • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST SEZ6, CONJUGATED TO (2S)-2-(2-BROMOACETAMIDO)-N-... (as listed) for Small cell lung cancer
  • TALQUETAMAB for Multiple myeloma|Newly diagnosed transplant-eligible multiple myeloma
  • OXALIPLATIN for High-risk stage III colon cancer
  • BALSTILIMAB for Basal cell carcinoma | Squamous cell carcinoma of the skin | Non-melanoma skin cancer
  • VIGABATRIN for Infantile spasms (infantile spasm syndrome) | Tuberous sclerosis complex | Hypoxic-ischemic encephalopathy | Intraventricular haemorrhage (grade IV) | Periventricular leukomalacia
  • OLAPARIB for High-grade serous ovarian cancer | Endometrioid ovarian cancer | Fallopian tube cancer | Primary peritoneal cancer
  • AZATHIOPRINE for Myocarditis | Inflammatory cardiomyopathy
  • CIT-013 for Rheumatoid arthritis
  • Fenofibrate micronised for Type 1 diabetes mellitus
  • Letermovir for Cytomegalovirus (CMV) infection in heart transplant recipients
  • TEZEPELUMAB for Chronic obstructive pulmonary disease (COPD)
  • CINNARIZINE for Heart failure with preserved ejection fraction